President Donald Trump’s April 15th executive order, “Lowering Drug Prices by Once Again Putting Americans First”, contained ...

Using advanced imaging technologies as a means to enhance diagnostic accuracy was also of interest. Many HCPs pointed to the ...

AstraZeneca's three-drug inhaler Breztri Aerosphere has shown efficacy for uncontrolled asthma in a pair of phase 3 trials ...

"DHE plays a unique clinical role in the acute treatment of migraine, providing patients long-lasting effects and the unique ...

The application has been submitted by the capital investment arm of insurance company Aviva and mixed-use developer Socius, ...

Shares in Eli Lilly have weakened after CVS Health, one of the largest pharmacy benefit managers (PBMs) in the US, said it ...

A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

Informed consent is a foundational element of every clinical trial. Yet, the traditional paper-based process has long been ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

The NEJM has fired back a response to the Department of Justice (DoJ) asserting its "commitment to evidence-based ...

How does market access impact the pharmaceutical commercialisation journey, and what role does it play in driving success ...